We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Autologous Fibroblast Grafts in Facial Skin Regeneration

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by LYDIA MASAKO FERREIRA, Federal University of São Paulo.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01490554
First Posted: December 13, 2011
Last Update Posted: July 24, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
LYDIA MASAKO FERREIRA, Federal University of São Paulo
December 9, 2011
December 13, 2011
July 24, 2012
March 2007
March 2011   (Final data collection date for primary outcome measure)
Regeneration of facial ectoderm [ Time Frame: one year after the grafting of autologous fibroblasts. ]
To evaluate the presence of skin changes after grafting of autologous fibroblasts by means of biophysical, histological, immunohistological, gene expression, glycosaminoglycan, and sensitivity analyses.
Same as current
Complete list of historical versions of study NCT01490554 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Autologous Fibroblast Grafts in Facial Skin Regeneration
Effectiveness of Autologous Fibroblast Grafts in the Regeneration of Facial Ectoderm
The purpose of this study is to evaluate the presence of skin changes after grafting of autologous fibroblasts by means of biophysical, histological, immunohistological, gene expression, glycosaminoglycan, and sensitivity analyses.
- Analytical prospective autocontrolled study
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Skin Aging
Procedure: autologous fibroblasts grafts
Autologous cultured fibroblasts will be grafted in facial skin
Experimental: autologous fibroblast grafts
autologous fibroblast grafts
Intervention: Procedure: autologous fibroblasts grafts
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
20
December 2012
March 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women, aged between 50 to 70 years with facial wrinkles (rhytides),
  • Fitzpatrick III skin type, and
  • Who had reached menopause at least 3 years before entering the study were eligible for participation.

Exclusion Criteria:

  • Women with uncontrolled comorbid conditions,
  • Smokers,
  • Alcohol and corticosteroid users,
  • Who had undergone chemical peeling or skin filling in the face or neck at least 12 months prior to the study,
  • Who had a keloid scar,
  • Who scored below 18 on the Mini-Mental State Examination,
  • Who had any psychiatric disorder or those undergoing orthodontic treatment were excluded from the study.
Sexes Eligible for Study: Female
50 Years to 70 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01490554
CEP UNIFESP-1787/07
Yes
Not Provided
Not Provided
LYDIA MASAKO FERREIRA, Federal University of São Paulo
Federal University of São Paulo
Not Provided
Principal Investigator: Lydia M Ferreira, MD, PhD Federal University of Sao Paulo
Federal University of São Paulo
July 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP